US and China Will Drive Cancer Companion Diagnostics Market Value to $670 Million by 2020
- Written by PitchEngine.com.au
The US will remain the leading market for cancer companion diagnostics, with its value expanding from $262.4 million in 2014 to an estimated $365.4 million by 2020, when it will account for just over 54% of the projected global share.
Reportstack’s report "MediPoint: Companion Diagnostic Tests in Oncology - Global Analysis and Market Forecasts...
Read more: US and China Will Drive Cancer Companion Diagnostics Market Value to $670 Million by 2020

